Physician profile

Junya Higuchi: From Stem Cell Research to Regenerative Medicine in Ginza

A structured profile following Ginza YR Clinic's official article format, covering Dr. Higuchi's background, publications, credentials, interview themes, and clinical approach.

Dr. Junya Higuchi

Junya Higuchi

Director, Ginza YR Clinic

MD, PhD. Graduate School of Medicine, University of Tokyo, with research focused on mesenchymal stem cells and osteoarthritis.

Short answer

Dr. Junya Higuchi is the director of GINZA YR CLINIC in Ginza, Tokyo. He holds a PhD in medicine from the University of Tokyo Graduate School of Medicine and is a board-certified orthopedic specialist (JOA), a certified regenerative medicine physician (JSRM) and a certified sports doctor (JSPO). His doctoral research focused on adipose-derived stem cells and osteoarthritis, and in 2020 he was first author of a clinical study of intra-articular stem cell injection for knee osteoarthritis in Regenerative Therapy, the JSRM's official journal.

PositionDirector, GINZA YR CLINIC (Ginza, Tokyo)
EducationUniversity of Tsukuba School of Medicine; PhD, University of Tokyo Graduate School of Medicine
CertificationsOrthopedic specialist (JOA); certified regenerative medicine physician (JSRM); sports doctor (JSPO)
ResearchAdipose-derived mesenchymal stem cells, osteoarthritis
Key paperRegenerative Therapy, 2020 (first author), DOI 10.1016/j.reth.2020.04.003
Public record10 peer-reviewed papers, 14 conference presentations; 20,000+ outpatient cases, 1,000+ surgeries (per the clinic's website)

Key public facts

University of Tokyo

PhD in Medicine

10

Peer-reviewed papers

14

Academic presentations

20,000+

Outpatient cases

1,000+

Surgeries

Why His Background Matters

Dr. Higuchi graduated from the University of Tsukuba School of Medicine, trained at St. Mary's Hospital, and later developed orthopedic expertise at the University of Tokyo across joint, spine, trauma, and sports medicine.

During his doctoral work at the University of Tokyo, he focused on mesenchymal stem cell research, especially adipose-derived stem cells and osteoarthritis. This background supports a more careful discussion of indication, risk, and clinical judgment.

Research and Clinical Experience

According to the clinic's official article, his lead-authored paper was published in Regenerative Therapy, the official journal of the Japanese Society for Regenerative Medicine, and examined clinical outcomes and MRI findings after autologous adipose-derived stem cell injections for knee osteoarthritis.

The profile also lists academic presentations in Japan and overseas, plus co-authored papers related to cartilage degradation and chondrogenic potential of stem cells.

Three Specialist Credentials

Dr. Higuchi holds certifications as an orthopedic specialist, a certified regenerative medicine physician, and a sports doctor. For patients considering care in Japan, this combination helps frame regenerative medicine alongside orthopedic disease, sports injury, and suitability assessment.

Interview Perspective

In the official interview, Dr. Higuchi emphasizes evidence-based care. Regenerative medicine may become an additional option when standard therapies are limited or when highly invasive procedures would otherwise be considered, but accurate diagnosis and careful indication assessment remain essential.

He also notes that the field continues to evolve, and that safety management, suitability assessment, outcome evaluation, and patient wishes should all be considered together.

Interview highlights (from the clinic's article)

Q1: Which of your 10 papers is most meaningful?

Dr. Higuchi notes that every paper is meaningful, regardless of author order, and expresses gratitude to mentors and colleagues involved in the work.

Q2: Why regenerative medicine?

He frames regenerative medicine as an additional evidence-based option when standard therapies are limited or when highly invasive treatment might otherwise be considered, while emphasizing diagnosis and indication assessment.

Q3: What about the broad use of the term regenerative medicine?

He acknowledges the hope carried by the term, but stresses that the field is still evolving and requires continued learning and clinical reflection.

Q4: What kind of care should Ginza YR Clinic offer?

The official interview highlights safety-first management, careful indication assessment, outcome evaluation, and sincere communication with each patient.

Frequently asked questions

What does Dr. Higuchi mainly see patients for?

Orthopedics and regenerative medicine: joint problems such as the knee, sports injuries, and assessing whether stem cell or PRP treatment is suitable. For the clinic's skin, hair and immune cell plans, the clinic explains at consultation which physician is responsible.

What language is the consultation in?

The doctor consults in Japanese, and our Chinese-speaking advisor interprets throughout. Records and test results can be translated into Japanese beforehand.

Can I ask to see Dr. Higuchi?

Yes, you can ask for him when booking; the final arrangement depends on the clinic's schedule.

Where can I verify his credentials and publications?

The paper is available via DOI 10.1016/j.reth.2020.04.003; the clinic's treatment plans can be looked up by number in the MHLW public lists; society certifications are listed on the clinic's website and by each society.

What should I bring to the first consultation?

A recent check-up report, relevant imaging (for example knee X-ray or MRI), a list of current medication and past treatment records. The first visit is an assessment; no treatment is given that day.

Do I have to go ahead with treatment after the consultation?

No. The consultation is to judge suitability, options and risks. If the doctor finds it unsuitable, or you decide against it, you can stop there.

Book a consultation

Tell an advisor about your situation

Share your questions and when you might travel. An advisor will reply within 24 hours.

See how it works